Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2009
10/22/2009US20090263444 Fluocinolone Formulations in a Biodegradable Polymer Carrier
10/22/2009US20090263427 Vaccines for mycoplasma bovis and methods of use
10/22/2009US20090263421 Cellular vaccine
10/22/2009US20090263404 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
10/22/2009US20090263403 DNAX Accessory Protein, 12 kD (DAP12); useful in modulating development of cells such as lymphoid and myeloid; for modulating of immune responses; fusion proteins
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263392 Methods of modifying antibodies for purification of bispecific antibodies
10/22/2009US20090263389 Use of TGF-Beta Antagonists to Treat or to Prevent Chronic Transplant Rejection
10/22/2009US20090263384 Agents for Suppressing the Induction of Cytotoxic T Cells
10/22/2009US20090263381 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
10/22/2009US20090263378 Methods of identifying anti-inflammatory compounds
10/22/2009US20090263358 autologously transplanting hematopoietic progenitor cell population which has been treated with antibody (monoclonal, chimeric, or humanized; not conjugated to toxin or cytolytic agent); radiotherapy
10/22/2009US20090263351 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
10/22/2009US20090263347 Analysis of amino acid copolymer compositions
10/22/2009US20090263335 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
10/22/2009US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines
10/22/2009DE102005027956B4 Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen Poxvirusstämme highly attenuated, processes for their preparation and their use as paramunity inducers or for the preparation of vector vaccines
10/22/2009CA2721434A1 Inhibitors of phosphatidylinositol 3-kinase
10/21/2009EP2110669A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
10/21/2009EP2110434A1 Type-1 cytokine receptor GLM-R
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP2110140A1 Treatment of thromboangiitis obliterans by removal of autoantibodies
10/21/2009EP2110134A1 Cocoa extract compounds and methods for making and using the same
10/21/2009EP2110132A1 Use of deuterium oxide as elastase inhibitor
10/21/2009EP2109607A1 Pyrrolo[3, 2-a]pyridine derivatives for inhibiting ksp kinesin activity
10/21/2009EP2109606A1 Chromene s1p1 receptor antagonist
10/21/2009EP2109459A1 Archaeal polar lipid aggregates for administration to animals
10/21/2009EP2109455A2 Compositions and methods for stimulating an immune response
10/21/2009EP2044046B1 Substituted n-acyl homoserine lactones
10/21/2009EP1984006B1 Conditioned blood composition and method for its production
10/21/2009EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009EP1512404B1 External preparations for treating dermatitis
10/21/2009EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009EP1207877B1 Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids
10/21/2009EP1109576B1 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
10/21/2009EP0959899B9 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
10/21/2009CN101563106A Combination of nmda- receptor ligand and a compound with 5-HT6 receptor affinity
10/21/2009CN101560460A Health wine and preparing method thereof
10/21/2009CN101560260A Technique for extracting polysaccharide in glossy ganoderma mycelium cell and method thereof
10/21/2009CN101560246A Thymopentin derivate, preparation method and application of derivate and compound containing derivate in preparing drugs
10/21/2009CN101559214A Composition having effect of enhancing immunity function and usage thereof
10/21/2009CN101559209A Chinese materia medica preparation for treating urticaria
10/21/2009CN101559184A Chinese materia medica preparation for treating eczema
10/21/2009CN101559159A Formulation of lily lotus seed oral liquid and preparation method thereof
10/21/2009CN101559156A Application of traditional Chinese medicine composition in preparing medicament for curing chronic inflammatory demyelinating polyneuropathy
10/21/2009CN101559145A Novel pure traditional Chinese medicine capsule preparation for preventing and curing premature senility and preparation method thereof
10/21/2009CN101559140A Micelle solution for immune regulation
10/21/2009CN101559119A Edible fungi composition and application thereof
10/21/2009CN101559095A Veterinary compound acanthopanax granules with immunopotentiation and preparation method thereof
10/21/2009CN101559091A Oral buccal tablet for quickly eliminating fatigue and strengthening immunity of organisms
10/21/2009CN101559088A Production technique of andrographolide and neoandrographolide, dehydroanddrographolide, oxyandrographolide
10/21/2009CN101559073A Cordyceps and ganoderma lucidum polysaccharides compound preparation with immune synergism
10/21/2009CN101559071A Application of 5' nucleotide in preparation of medicines and health-care foods for improving weakened immune function
10/21/2009CN101559051A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on melanoma
10/21/2009CN101559050A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on immune system
10/21/2009CN101558875A Granule prepared by camellia chrysantha tea and preparation method thereof
10/21/2009CN101558870A Mulberry and sea backthern concentrated food
10/21/2009CN101558810A Teabag containing paeoniifolia for improving immunity and manufacturing method thereof
10/21/2009CN100552016C Bifidobacterium in treatment of inflammatory disease
10/21/2009CN100551930C Peptides modulating caspase activation
10/21/2009CN100551364C Medicine use of 3 (3 nitryl-4-hydroxy)phenyl acrylate in preparing medicine for controlling xanthine oxidase
10/21/2009CN100551360C Radix Isatidis effervescence tablet and preparation method thereof
10/21/2009CA2629547A1 Compositions of phosphodiesterase type iv inhibitors
10/20/2009US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009US7605258 Preparing an individual isomer of mono-pegylated rapamycin 42 ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) by reacting an isomer of rapamycin with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid; use in treating nerve system cancer, leukemia, breast cancer, prostate cancer
10/20/2009US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7604955 Detection of peptides which induce cytotoxic t-lymphocytes; provide imunoglobulin test peptide, incubate with cells, monitor mammalian cytotoxic T- lymphocyte response, isolate peptide which induce response
10/20/2009US7604822 Injectable solution with anti-inflammatory effect and process for manufacturing the same
10/20/2009US7604803 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic
10/20/2009US7604802 Vaccine composed with protein particle antigen and excipient; especially to elicit cytotoxic-T lymphocyte response.
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2456127C Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
10/20/2009CA2446712C System for osmotic delivery of pharmaceutically active agents
10/20/2009CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009CA2376894C Pharmaceutical composition comprising a protein and an ectoine
10/20/2009CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use
10/15/2009WO2009126877A2 Methods and compositions for accelerating the generation of regulatory tcells ex vivo
10/15/2009WO2009126835A2 Magnetic nanoparticle and method for imaging t cells
10/15/2009WO2009126737A2 Triterpene saponins, methods of synthesis, and uses thereof
10/15/2009WO2009126688A2 Novel compositions and methods for the treatment of immune related diseases
10/15/2009WO2009126515A1 Compounds and compositions as protein kinase inhibitors
10/15/2009WO2009126514A1 Compounds and compositions as kinase inhibitors
10/15/2009WO2009125841A1 Process for production of ethynylthymidine compound using 5-methyluridine as starting raw material
10/15/2009WO2009125168A1 New combination for use in the treatment of inflammatory disorders
10/15/2009WO2009125017A2 Process for the extraction of mangiferin and isomangiferin
10/15/2009WO2009124815A1 Agent for treating disease
10/15/2009WO2009124381A1 An anti-cancer cytotoxic monoclonal antibody
10/15/2009WO2009124362A1 Suppressor of the endogenous interferon- gamma
10/15/2009WO2009124353A1 Modified cpn10 and prr signalling
10/15/2009WO2009124333A1 Modified chaperonin 10 and prr signaling
10/15/2009WO2009053718A3 Immuno-modulatory composition
10/15/2009WO2009043465A3 Use of beta-endorphin as a therapeutic agent
10/15/2009WO2009033780A3 Use of growth hormone-releasing factor and/or k237 as a therapeutic agents
10/15/2009WO2009033768A3 Use of a peptide as a therapeutic agent
10/15/2009US20090258936 Cxcr2 inhibitors
10/15/2009US20090258922 Compound exhibiting pgd2 receptor antagonist
1 ... 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 ... 1172